MindWalk Holdings (HYFT) Liabilities from Discontinued Operations (2025)

MindWalk Holdings (HYFT) reported Liabilities from Discontinued Operations of 8900086.8 for Q3 2025.

MindWalk Holdings (HYFT) Liabilities from Discontinued Operations (2025) Analysis & Trends

MindWalk Holdings (HYFT) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 8900086.8 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 MindWalk Holdings 166.20 Mn 156.06 Mn 1.78

Historic Data

Download Data
DateValue
Jul 31, 2025 8.90 Mn
Jul 31, 2025 8.90 Mn